Treat your patients to Tria

When it comes to ureteral stents, urine calcium (Ca) and magnesium (Mg) salt deposits can contribute to stent complications such as encrustation.^1,2 The cause and rate of encrustation is multifactorial and can include factors such as body chemistry and medical condition of the patient, stent indwell time, and surface material or properties of the stent.^2-4 The Tria Stent is the only commercially available stent that may help control the accumulation of both Mg and Ca salts.^5,6

The Tria Stent is designed to be stiffer during placement to navigate patient anatomy while softening by over 40% at body temperature,^5,7 which may promote greater patient tolerability.⁸